Assessing kinetic and epitopic diversity across orthogonal monoclonal antibody generation platforms

Abstract excerpt

The ability of monoclonal antibodies (mAbs) to target specific antigens with high precision has led to an increasing demand to generate them for therapeutic use in many disease areas. Historically, the discovery of therapeutic mAbs has relied upon the immunization of mammals and various in vitro display technologies. While the routine immunization of rodents yields clones that are stable in serum and have been...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Monoclonal and Polyclonal Antibodies Research
• Share to Transgenic Plants and Applications
• Share to Viral Infectious Diseases and Gene Expression in Insects